Management of high-risk melanoma.

Bonaccorsi, P; Ansel, J C; Armstrong, C A

Bonaccorsi, P; Ansel, J C; Armstrong, C A.

Afiliación

Bonaccorsi P; Department of Dermatology, Emory University School of Medicine, Veterans Affairs Medical Center, Atlanta, Georgia, USA.

Dermatol Clin ; 19(4): 727-35, 2001 Oct.

Article en En | MEDLINE | ID: mdl-11705357

RESUMEN

Improved treatment options for patients with high-risk melanoma are of great importance for clinicians who participate in the care of these patients. There remains an overall lack of response to existing treatment options, which continues to fuel the efforts of basic scientists and clinicians to pursue other approaches for the treatment of melanoma that is no longer limited to the skin. Continued investigation into the innovative and concurrent use of surgery, chemotherapy, immunotherapy, and radiation therapy holds significant promise for improved outcomes in the management of patients with this devastating disease.

Asunto(s)

Melanoma/terapia; Neoplasias Cutáneas/terapia; Vacunas contra el Cáncer/uso terapéutico; Terapia Genética; Humanos; Melanoma/diagnóstico; Pronóstico; Factores de Riesgo; Biopsia del Ganglio Linfático Centinela; Neoplasias Cutáneas/diagnóstico

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Dermatol Clin Año: 2001 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links